Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zefeng Xu

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Haematologica|July 6, 2014
Calreticulin mutations in Chinese with primary myelofibrosisBing Li, Junqing Xu, Jingya Wang, et al.
Leukemia & Lymphoma|May 7, 2019
Prognostic mutations in persons with isolated neutropenia myelodysplastic syndromeZhongxun Shi, Tiejun Qin, Zefeng Xu, et al.
American Journal of Hematology|July 22, 2014
Monosomal karyotype is an independent predictor of survival in patients with higher-risk myelodysplastic syndromeRuixian Xing, Chengwen Li, Robert Peter Gale, et al.
Leukemia Research Reports|March 27, 2023
Case of cryptic <i>TNIP1::PDGFRB</i> rearrangement presenting with myelodysplastic syndrome achieved hematologic and cytogenetic remission with low-dose imatinib plus decitabine therapyShiqiang Qu, Yiru Yan, Chengwen Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 21, 2016
[Clinical and laboratory characteristics in patients of myelodysplastic syndrome with PNH clones]Yan Li, Tiejun Qin, Zefeng Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 25, 2014
[A study of prognostic value of cytogenetics in patients with primary myelofibrosis]Bing Li, Junqing Xu, Zefeng Xu, et al.
Leukemia & Lymphoma|June 24, 2023
Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and <i>FGFR1</i> rearrangementYiru Yan, Shiqiang Qu, Jinqin Liu, et al.
American Journal of Hematology|August 19, 2014
Cytogenetic studies and their prognostic contribution in 565 Chinese patients with primary myelofibrosisBing Li, Junqing Xu, Chengwen Li, et al.
Leukemia Research|March 7, 2014
Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusionsRui Cui, Robert Peter Gale, Guoqing Zhu, et al.
Blood Cancer Journal|January 17, 2018
Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia responseXueping Luo, Zefeng Xu, Bing Li, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Haematologica|July 6, 2014
Calreticulin mutations in Chinese with primary myelofibrosisBing Li, Junqing Xu, Jingya Wang, et al.
Leukemia & Lymphoma|May 7, 2019
Prognostic mutations in persons with isolated neutropenia myelodysplastic syndromeZhongxun Shi, Tiejun Qin, Zefeng Xu, et al.
American Journal of Hematology|July 22, 2014
Monosomal karyotype is an independent predictor of survival in patients with higher-risk myelodysplastic syndromeRuixian Xing, Chengwen Li, Robert Peter Gale, et al.
Leukemia Research Reports|March 27, 2023
Case of cryptic <i>TNIP1::PDGFRB</i> rearrangement presenting with myelodysplastic syndrome achieved hematologic and cytogenetic remission with low-dose imatinib plus decitabine therapyShiqiang Qu, Yiru Yan, Chengwen Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 21, 2016
[Clinical and laboratory characteristics in patients of myelodysplastic syndrome with PNH clones]Yan Li, Tiejun Qin, Zefeng Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 25, 2014
[A study of prognostic value of cytogenetics in patients with primary myelofibrosis]Bing Li, Junqing Xu, Zefeng Xu, et al.
Leukemia & Lymphoma|June 24, 2023
Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and <i>FGFR1</i> rearrangementYiru Yan, Shiqiang Qu, Jinqin Liu, et al.
American Journal of Hematology|August 19, 2014
Cytogenetic studies and their prognostic contribution in 565 Chinese patients with primary myelofibrosisBing Li, Junqing Xu, Chengwen Li, et al.
Leukemia Research|March 7, 2014
Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusionsRui Cui, Robert Peter Gale, Guoqing Zhu, et al.
Blood Cancer Journal|January 17, 2018
Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia responseXueping Luo, Zefeng Xu, Bing Li, et al.
Pageof 13